Bottom line
ECHSX vs SHSSX: the short answer
ECHSX (Eaton Vance Worldwide Health Sciences Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.
But SHSSX is far broader, holding 155 positions to 42 for ECHSX, so beyond the top names it adds exposure ECHSX doesn't have.
SHSSX is cheaper at 0.86% vs 1.93% — a difference of $107 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +5.6% for ECHSX (reporting dates differ).
Updated Nov 19, 2026
ECHSX vs SHSSX side by side
| ECHSX | SHSSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.93% | 0.86% |
| Annual cost per $10k | $193 | $86 |
| 10-yr cost on $10k (prospectus) | $2,089 | $1,061 |
| Max front load | 0% | 0% |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +1.7% | +16.3% |
| 5-yr return (annualized) | +5.6% | +5.9% |
| 10-yr return (annualized) | +6.3% | +9.8% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $757.9M | $5.9B |
| Number of holdings | 42 | 155 |
| Portfolio turnover | 3% | 49% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of ECHSX's top 25 holdings also appear in SHSSX's top 25.
| Holding | ECHSX | SHSSX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 12.29% |
| AbbVie Inc | 6.46% | 3.94% |
| Johnson & Johnson | 6.45% | 8.77% |
| AstraZeneca PLC | 6.24% | 1.21% |
| UnitedHealth Group Inc | 5.49% | 6.10% |
| Merck & Co Inc | 5.08% | 4.94% |
| Vertex Pharmaceuticals Inc | 3.38% | 2.74% |
| Gilead Sciences Inc | 3.34% | 4.19% |
| Thermo Fisher Scientific Inc | 2.79% | 3.02% |
| Intuitive Surgical Inc | 2.72% | 1.95% |
| Stryker Corp | 2.21% | 1.15% |
| Boston Scientific Corp | 2.18% | 1.59% |
| Abbott Laboratories | 1.65% | 1.97% |
| Argenx SE | 1.61% | 1.26% |
Source: SEC Form N-PORT
ECHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between ECHSX and SHSSX?
Which is cheaper, ECHSX or SHSSX?
Should I own both ECHSX and SHSSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.